**INTRODUCTION:** Accurate knowledge of the nature and frequency of complications is critical for evaluation of the safety and efficacy of surgical interventions. Historically, complications in surgical trials have been poorly reported. This investigation aimed to systematically evaluate the reporting of complications in the plastic surgery (PS) literature.

**METHODS:** Two independent reviewers conducted a systematic search using the electronic databases MEDLINE, EMBASE, and SCOPUS. The search was limited to the top seven plastic surgery journals with the highest impact factors. Randomized controlled trials (RCTs), describing a potentially invasive treatment, in any domain of PS, published between 2012--2016, were included.

**RESULTS:** One hundred and forty-five RCTs met our inclusion criteria, of which 30% were registered. Anticipated complications were clearly defined in only 15% of studies, and in 70% of studies it was not clear who would be documenting the complications that arose. Furthermore, only 72% of studies reported the occurrence of complications, of which 61% did not discuss events occurring in the intra-interventional period. Of the studies not documenting a complication, two-thirds included a statement declaring that no complications had occurred. Pain was the most common intra- and post-interventional complication. Binary logistic regression revealed that after controlling for potential confounders, funded RCTs were nearly four times more likely to report complications (95% CI 1.41--10.83, *p*=0.009).

**CONCLUSION:** Reporting of complications in the PS literature remains heterogeneous. Improved transparency and evaluation of complications will strengthen evidenced-based practice and improve patient outcomes. We propose a standardization tool for assessing and reporting complications in PS trials.
